Study to Investigate the Efficacy and Safety of an Investigational Medication in Patients with Alopecia Areata

Last Updated:
10/27/2020
Status:
Recruiting
Country:
United States
Eligibility:
Age 18+; diagnosed with alopecia areata (50% or greater scalp hair loss)
Drug:
SHR0302
Administration:
Oral
Sponsor: 
Reistone Biopharma

A clinical research study is currently looking for adults with alopecia areata who have lost 50% or more of the hair on their head to participate in a study of an investigational medication. During the course of this study, some people will receive the investigational medication, and some will receive an inactive medication called a placebo. The study will explore whether the study drug is safe and can help alopecia areata patients regrow hair. The study drug, using different doses, will be compared to an inactive placebo (dummy drug).

You may qualify to participate if you:

  • are 18 years of age or older
  • have been diagnosed with alopecia areata
  • have at least 50% scalp hair loss*
*study doctor will assess your amount of hair loss.

If you or someone you know is interested in joining this clinical trial, please contact the most convenient trial site listed below for more Information:

Quest Dermatology Research
Northridge, CA
Contact: Melissa Banez
Phone: 818-885-0455

Moore Clinical Research
Brandon, FL
Contact: Judy Keene
Phone: 813-948-7550 x 302

Dawes Fretzin Clinical Research Group, LLC
Indianapolis, IN
Contact: Elissa O’Malley
Phone: 317-516-5030 x 193

Skin Search of Rochester
Rochester, NY
Contact: Denise Forster
Phone: 585-697-1818

Dermatologists of Southwest Ohio
Mason, OH
Contact: Erica Mihaltian
Phone: 513-701-5526 x 5114

The Skin Wellness Center
Knoxville, TN
Contact: Kim Brefini
Phone: 865-251-9963

Progressive Clinical Research
San Antonio, TX
Contact: Ryann Magee
Phone: 210-614-5557